HMGB1 and Headache: They found that the serum level of high mobility group box-1 (HMGB1), Nod-like receptor pyrin domain-containing 3 (NLRP3), angiotensin-converting enzyme 2 (ACE2), and IL-6 was significantly higher among COVID-patients with headache compared patients without it.